Annual Drug Patent Expirations for UTIBRON Utibron is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are eighteen patents protecting…
The post New patent expiration for Novartis drug UTIBRON appeared fi…
SEEBRI (glycopyrrolate) Novartis Patent: 7,229,607 Expiration: Apr 9, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug P…
Drug Patent Expirations for the Week of April 4, 2021 Read Post »
Annual Drug Patent Expirations for XEPI Xepi is a drug marketed by Ferrer Internacional and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent expiration for Ferrer Internacional drug XEPI appeared …
New patent expiration for Ferrer Internacional drug XEPI Read Post »
Annual Drug Patent Expirations for PHOSLO Phoslo is a drug marketed by Fresenius Medcl and is included in two NDAs. It is available from three suppliers. There are two patents…
The post New patent expiration for Fresenius Medcl drug PHOSLO appeared fir…
New patent expiration for Fresenius Medcl drug PHOSLO Read Post »
Annual Drug Patent Expirations for PHOSLO+GELCAPS Phoslo Gelcaps is a drug marketed by Fresenius Medcl and is included in one NDA. It is available from three suppliers. There are two…
The post New patent expiration for Fresenius Medcl drug PHOSLO GELCA…
New patent expiration for Fresenius Medcl drug PHOSLO GELCAPS Read Post »
ONPATTRO (patisiran sodium) Alnylam pharms inc Patent: 8,895,721 Expiration: Mar 30, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations fo…
Drug Patent Expirations for the Week of March 28, 2021 Read Post »
Annual Drug Patent Expirations for ONPATTRO Onpattro is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are twenty-one patents protecting this drug. Drug patent…
The post New patent expiration for Alnylam Pharms drug ONPATTRO ap…
New patent expiration for Alnylam Pharms drug ONPATTRO Read Post »
Annual Drug Patent Expirations for ONPATTRO Onpattro is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are twenty-one patents protecting this drug. Drug patent…
The post New patent expiration for Alnylam Pharms drug ONPATTRO ap…
New patent expiration for Alnylam Pharms drug ONPATTRO Read Post »
Annual Drug Patent Expirations for NEUPRO Neupro is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Ucb Inc drug NEUPRO appeared first on DrugPatentWa…
Annual Drug Patent Expirations for NEUPRO Neupro is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Ucb Inc drug NEUPRO appeared first on DrugPatentWa…